Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

HAL Allergy B.V.

The Netherlands J.h. Oortweg 15-17, 2333 CH Leiden, The Netherlands

About the sponsor

HAL Allergy B.V. focuses on moderate to severe allergic rhinitis and rhinoconjunctivitis linked to house dust mite sensitisation, including persistent nasal and ocular allergy symptoms in adults.

  • Allergic rhinitis
  • Rhinoconjunctivitis
  • House dust mite allergy

The sponsor’s clinical interest is centred on allergy-driven upper airway disease and symptom control in affected adult populations.

About Specializations

HAL Allergy B.V. runs clinical trials in conditions such as Conjunctivitis allergic, Rhinitis allergic, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Conjunctivitis allergic+1

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.